(Q39093233)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

Corrigendum: An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.

9 April 2020

corrigendum / erratum

0 references

author

Farjana Khatun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Rachel J Stephenson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Istvan Toth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

author name string

Farjana Khatun

1

1 reference

9 September 2017

Rachel J Stephenson

2

1 reference

9 September 2017

Istvan Toth

3

1 reference

9 September 2017

language of work or name

English

0 references

publication date

18 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

Chemistry—A European Journal

9 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

4233-4254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

Carbohydrate vaccines: developing sweet solutions to sticky situations?

9 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Carbohydrates and T cells: a sweet twosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Polysaccharide processing and presentation by the MHCII pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

How bacterial carbohydrates influence the adaptive immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Recent mechanistic insights on glycoconjugate vaccines and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

The design of semi-synthetic and synthetic glycoconjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

The love-hate relationship between bacterial polysaccharides and the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

CHAPTER 3. Carbohydrate Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Synthetically defined glycoprotein vaccines: current status and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Unique chemical reactivity of His-21 of CRM-197, a mutated diphtheria toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Vaccines based on the cell surface carbohydrates of pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Two or three primary dose regime for Haemophilus influenzae type b conjugate vaccine: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Protective activity of a glycoconjugate based on a synthetic hexasaccharide related to a fragment of capsular Streptococcus pneumoniae serotype 14 polysaccharide chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Chemical Synthesis Elucidates the Immunological Importance of a Pyruvate Modification in the Capsular Polysaccharide of Streptococcus pneumoniae Serotype 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Review: current and new generation pneumococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

New conjugate vaccines for the prevention of pneumococcal disease in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Decomposing Indigenous life expectancy gap by risk factors: a life table analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Synthesis and immunological evaluation of protein conjugates of Neisseria meningitidis X capsular polysaccharide fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Process development and immunogenicity studies on a serogroup 'X' Meningococcal polysaccharide conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Impact of meningococcal C conjugate vaccine in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Molecular mimetics of Neisseria meningitidis serogroup B polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

A universal vaccine for serogroup B meningococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Towards a synthetic glycoconjugate vaccine against Neisseria meningitidis A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Relative stability of meningococcal serogroup A and X polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Discovery and characterization of sialic acid O-acetylation in group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Group B Streptococcus vaccine: state of the art

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Structural elucidation of type III group B Streptococcus capsular polysaccharide using molecular dynamics simulations: the role of sialic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Glycoconjugate vaccines to prevent group B streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Group B streptococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Development of Vi conjugate - a new generation of typhoid vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Anti-carbohydrate antibodies for the detection of anthrax spores

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Immuno-detection of anthrose containing tetrasaccharide in the exosporium of Bacillus anthracis and Bacillus cereus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Anthrax spore detection by a luminex assay based on monoclonal antibodies that recognize anthrose-containing oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Photogenerated glycan arrays identify immunogenic sugar moieties of Bacillus anthracis exosporium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Synthesis and immunochemical evaluation of a non-methylated disaccharide analogue of the anthrax tetrasaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

The structure of the major cell wall polysaccharide of Bacillus anthracis is species-specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Endolysins of Bacillus anthracis bacteriophages recognize unique carbohydrate epitopes of vegetative cell wall polysaccharides with high affinity and selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Role of lipoteichoic acid in the phagocyte response to group B streptococcus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Chemical biology approaches to designing defined carbohydrate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Clostridium difficile PSI polysaccharide: synthesis of pentasaccharide repeating block, conjugation to exotoxin B subunit, and detection of natural anti-PSI IgG antibodies in horse serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Tools for glycomics: mapping interactions of carbohydrates in biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

The promise of glycomics, glycan arrays and carbohydrate-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Adaptive immune activation: glycosylation does matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Streptococcus and rheumatic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Clinical Studies of Escherichia coli O157:H7 Conjugate Vaccines in Adults and Young Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Glycoconjugate vaccine containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein elicits humoral and cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Progress and pitfalls in Shigella vaccine research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Revised structures for the capsular polysaccharides from Staphylococcus aureus Types 5 and 8, components of novel glycoconjugate vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHEM.201603599

21 January 2018

Identifiers

DOI

10.1002/CHEM.201603599

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28097690%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference